These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7689037)

  • 41. Nitric oxide activates cyclooxygenase enzymes.
    Salvemini D; Misko TP; Masferrer JL; Seibert K; Currie MG; Needleman P
    Proc Natl Acad Sci U S A; 1993 Aug; 90(15):7240-4. PubMed ID: 7688473
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of aminoguanidine on nitric oxide production induced by inflammatory cytokines and endotoxin in cultured rat hepatocytes.
    Zhang GL; Wang YH; Teng HL; Lin ZB
    World J Gastroenterol; 2001 Jun; 7(3):331-4. PubMed ID: 11819785
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Autocrine/paracrine IFN-alphabeta mediates the lipopolysaccharide-induced activation of transcription factor Stat1alpha in mouse macrophages: pivotal role of Stat1alpha in induction of the inducible nitric oxide synthase gene.
    Gao JJ; Filla MB; Fultz MJ; Vogel SN; Russell SW; Murphy WJ
    J Immunol; 1998 Nov; 161(9):4803-10. PubMed ID: 9794412
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Induction by growth factors from platelets of the focus-forming transformed phenotype in carcinogen-treated C3H/10T1/2 fibroblasts.
    Mordan LJ
    Carcinogenesis; 1988 Jul; 9(7):1129-34. PubMed ID: 3383332
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Production of vascular endothelial growth factor by murine macrophages: regulation by hypoxia, lactate, and the inducible nitric oxide synthase pathway.
    Xiong M; Elson G; Legarda D; Leibovich SJ
    Am J Pathol; 1998 Aug; 153(2):587-98. PubMed ID: 9708818
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Iron regulates nitric oxide synthase activity by controlling nuclear transcription.
    Weiss G; Werner-Felmayer G; Werner ER; Grünewald K; Wachter H; Hentze MW
    J Exp Med; 1994 Sep; 180(3):969-76. PubMed ID: 7520477
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mechanistic differences between migration inhibitory factor (MIF) and IFN-gamma for macrophage activation. MIF and IFN-gamma synergize with lipid A to mediate migration inhibition but only IFN-gamma induces production of TNF-alpha and nitric oxide.
    Herriott MJ; Jiang H; Stewart CA; Fast DJ; Leu RW
    J Immunol; 1993 May; 150(10):4524-31. PubMed ID: 7683323
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enhanced expression and state of the c-myc oncogene in chemically and X-ray-transformed C3H/10T1/2 Cl 8 mouse embryo fibroblasts.
    Billings PC; Shuin T; Lillehaug J; Miura T; Roy-Burman P; Landolph JR
    Cancer Res; 1987 Jul; 47(14):3643-9. PubMed ID: 2439194
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ras downregulation of protein kinase C mRNA in C3H 10T1/2 fibroblasts.
    Fernandes ER; Ashendel CL
    Mol Carcinog; 1996 Sep; 17(1):23-34. PubMed ID: 8876672
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The inhibitory effects of mercaptoalkylguanidines on cyclo-oxygenase activity.
    Zingarelli B; Southan GJ; Gilad E; O'Connor M; Salzman AL; Szabó C
    Br J Pharmacol; 1997 Feb; 120(3):357-66. PubMed ID: 9031736
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interleukin 1 activates soluble guanylate cyclase in human vascular smooth muscle cells through a novel nitric oxide-independent pathway.
    Beasley D; McGuiggin M
    J Exp Med; 1994 Jan; 179(1):71-80. PubMed ID: 7505803
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Osteopontin is induced by nitric oxide in RAW 264.7 cells.
    Takahashi F; Takahashi K; Maeda K; Tominaga S; Fukuchi Y
    IUBMB Life; 2000 Mar; 49(3):217-21. PubMed ID: 10868913
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Downregulation of connective tissue growth factor by LPS/IFN-γ-induced nitric oxide is reversed by aristolochic acid treatment in glomerular mesangial cells via STAT-1α and NF-κB signaling.
    Tsai KD; Chen W; Wang SH; Hsiao YW; Chi JY; Wu HY; Lee YJ; Wong HY; Tseng MJ; Lin TH
    Chem Biol Interact; 2014 Mar; 210():86-95. PubMed ID: 24412304
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of chlorohydroxyfuranones on 3-methylcholanthrene-induced neoplastic transformation in the two-stage transformation assay in C3H 10T1/2 cells.
    Laaksonen M; Mäki-Paakkanen J; Kronberg L; Komulainen H
    Arch Toxicol; 2003 Oct; 77(10):594-600. PubMed ID: 14574448
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interferon-gamma/lipopolysaccharide-treated mouse embryonic fibroblasts are killed by a glycolysis/L-arginine-dependent process accompanied by depression of mitochondrial respiration.
    Dijkmans R; Billiau A
    Eur J Biochem; 1991 Nov; 202(1):151-9. PubMed ID: 1935971
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Promotion of morphological transformation by Di-n-butyltin dichloride in C3H/10T1/2 cells: prediction by prior expression of tumour promoter-responsive genes.
    Parfett CL; Marquardt T; Pilon R
    Food Chem Toxicol; 2000 Apr; 38(4):339-49. PubMed ID: 10722888
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nitric oxide synthase expression and nitric oxide production are reduced in hypertrophic scar tissue and fibroblasts.
    Wang R; Ghahary A; Shen YJ; Scott PG; Tredget EE
    J Invest Dermatol; 1997 Apr; 108(4):438-44. PubMed ID: 9077471
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nitric oxide synthase type-II is synthesized by human gingival tissue and cultured human gingival fibroblasts.
    Kendall HK; Haase HR; Li H; Xiao Y; Bartold PM
    J Periodontal Res; 2000 Aug; 35(4):194-200. PubMed ID: 10983879
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oncogenic transformation of C3H/10T1/2 Cl 8 mouse embryo fibroblasts by inhibitors of nucleotide metabolism.
    Peterson AR; Heidelberger C; Benedict WF
    Basic Life Sci; 1985; 31():465-79. PubMed ID: 3158305
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Morphological and neoplastic transformation of C3H/10T1/2 Cl 8 mouse embryo cells by insoluble carcinogenic nickel compounds.
    Miura T; Patierno SR; Sakuramoto T; Landolph JR
    Environ Mol Mutagen; 1989; 14(2):65-78. PubMed ID: 2548861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.